TurtleBK stated: "RECAF is exactly what cancer therapy needs to optimize the effectiveness of the current standard of care."
If the above is true, please explain why DR70/Onko-sure and the haah marker tests have not taken off like wildfire? Their performance is similar to RECAF. Why don't you check with a practicing oncologist and ask why he does not use the above tests?
Also, if it is not "harmful to the patient" to know that a slow growing cancer exists, why are the experts now saying to not use PSA for men over 75? I'll tell you why. Almost everyone has been conditioned that cancers kill and will not use "watchful waiting". Those opting for watchful waiting defect in huge numbers and have their prostates removed anyway. The number of unnecessary treatments are huge compared to the number of treatments that actually are needed.
Cancers in milk ducts are rarely if ever a problem yet today, huge numbers of women opt for treatment because they "know" "cancer kills". In screening, RECAF would largely find small cancers that do not need to be treated. Just like PSA, it would do more harm than good.
Question: Why do you think Abbott stopped any thoughts of commercializing RECAF?
